Exonate

A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety And Tolerability Of Exn407 In Subjects With Centre Involved Diabetic Macular Oedema Secondary To Diabetes Mellitus.

Study Type  : Interventional  (Clinical Trial)
Estimated Enrollment  : 48 participants
Allocation: Randomized
Intervention Model: Sequential Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
Actual Study Start Date  : November 5, 2020
Estimated Primary Completion Date  : March 28, 2022
Estimated Study Completion Date  : August 9, 2022

Related Publications

Our Affiliates